Progetti FP7 coordinati da "Universitaetsklinikum hamburg-eppendorf"
| # | ||||
|---|---|---|---|---|
| 1 | CUREHLH "European initiative to improve knowledge, treatment and survival of haemophagocytic syndromes in children" | 2008 | 3˙917˙550.00 | 2˙994˙942.00 |
| 2 | MENTDIS_ICF65+ "Prevalence, 1-year incidence and symptom severity of mental disorders in the elderly: Relationship to impairment, functioning (ICF) and service utilisation" | 2008 | 3˙919˙217.00 | 2˙997˙684.00 |
| 3 | HNO AND CVD Role of Nitroxyl (HNO) in the cardio and cerebrovascular system | 2009 | 167˙549.00 | 167˙549.00 |
| 4 | T3NET Tissue Transmigration Training Network | 2009 | 2˙857˙635.00 | 2˙857˙635.00 |
| 5 | DEPRESSION IN MS Pathogenetic mechanisms of depression in multiple sclerosis | 2010 | 100˙000.00 | 100˙000.00 |
| 6 | LEUKEMOGENESISAPL An in-vivo Screen for the Identification of Leukemia-Promoting Factors | 2010 | 100˙000.00 | 100˙000.00 |
| 7 | MULTISENSE The merging of the senses: understanding multisensory experience | 2011 | 3˙472˙800.00 | 3˙472˙800.00 |
| 8 | PLACEBO The placebo effect – a window into the relationship between mind and body | 2011 | 2˙499˙120.00 | 2˙499˙120.00 |
| 9 | DEM-CHILD A Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in Childhood | 2011 | 3˙971˙419.00 | 2˙998˙795.00 |
| 10 | BIOMARCARE Biomarker for Cardiovascular Risk Assessment in Europe | 2011 | 7˙847˙985.00 | 6˙000˙000.00 |
| 11 | EURHYTHDIA Chronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population | 2011 | 7˙695˙927.00 | 5˙997˙889.00 |
| 12 | WAKE-UP "Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial" | 2011 | 16˙050˙806.00 | 11˙599˙987.00 |
| 13 | CROSS-TALK IN BONE MOLECULAR REGULATION OF OSTEOBLAST MOTILITY AND THE BONE-VASCULAR NICHE | 2012 | 100˙000.00 | 100˙000.00 |
| 14 | IL-22 AND IL-22BP Identifying the immune and microbial network controlling the IL-22 – IL-22bp axis to open the doors for targeted therapies | 2014 | 1˙498˙392.00 | 1˙498˙392.00 |
| 15 | NET-LYSIS Degradation of Neutrophil Extracellular Traps and its impact on thrombolysis | 2014 | 168˙794.00 | 168˙794.00 |
| 16 | INDIVUHEART Individualized early risk assessment for heart diseases | 2014 | 2˙494˙728.00 | 2˙494˙728.00 |
Altri progetti
L'Ente universitaetsklinikum hamburg-eppendorf partecipato anche in questi progetti.
- PLACEBO (2011, hostInstitution)
- PLACEBO (2011, hostInstitution)
- BIODESIGN (2012, participant)
- EMTICS (2011, participant)
- EVERREST (2013, participant)
- SUREPIRL (2012, beneficiary)
- BIO-DRIM (2012, participant)
- RESOLVE (2013, participant)
- CHEMOGUIDE (2013, participant)
- SYBIL (2013, participant)
- EUROHEADPAIN (2014, participant)
- HBP (2013, participant)
- GANNET53 (2013, participant)
- IL-22 AND IL-22BP (2014, hostInstitution)
- IL-22 AND IL-22BP (2014, hostInstitution)
- INDIVUHEART (2014, hostInstitution)
- INDIVUHEART (2014, hostInstitution)
- MESA (2014, beneficiary)
- BESECU (2008, participant)
- RESPECT (2008, participant)
- GENINCA (2008, participant)
- HYPERIMAGE (2008, participant)
- BRAINSYNC (2008, participant)
- UEPHA-MS (2008, participant)
- ANGIOSCAFF (2008, participant)
- EUCogII (2009, participant)
- BIG-HEART (2010, participant)
- RICHE (2010, participant)
- BONE-NET (2011, participant)
- GLYCOBIOM (2011, participant)
- LEUKOTREAT (2010, participant)
- EUCogIII (2011, participant)
- MULTISENSE (2011, hostInstitution)
- DISSECT (2011, hostInstitution)